SureTrader
Home > Boards > US OTC > Medical - Drugs >

Entest BioMedical Inc. (ENTB)

ENTB RSS Feed
Add ENTB Price Alert      Hide Sticky   Hide Intro
Moderator: 1~Eye~Jack!!, sizzleweed
Search This Board:
Last Post: 2/12/2016 1:26:12 PM - Followers: 458 - Board type: Free - Posts Today: 0

 




 

http://www.entb.net


 

 

 

 

 

Company Information:                                                      
4700 Spring Street, Suite 304
La Mesa, Calif. 91942
Telephone: 619-644-3344
Fax: 619-330-2328
E-mail:
info@EntestBio.com

Web site: www.EntestBio.com

 

CIK 0001449447
 

ImenVax (TM)

Immuno-Therapeutic Cancer Treatment for Canines


 

In the encapsulated ImenVax™ device, a "cocktail" of integral immuno-catalysts are enclosed. From this ImenVax™ device immuno-catalysts are released which activate the patient's immune cell. These immune cells carry on their normal course of activity by entering the lymph nodes and cause T-Cell adaptation. These T-Cells are what attack and kill the tumor. (Figure 1)
 


Entest BioMedical Inc. (OTCQB: ENTB)is a majority owned subsidiary of Bio-Matrix Scientific Group Inc (OTCQB: BMSN). The Company is involved with the development of stem cell therapy treatments for Chronic Obstructive Pulmonary Disease (COPD), cancer immuno-therapies, testing procedures for diabetes and stem cell research applications for diabetes and other illnesses. The Company also is involved with medical device development (including stem cell extraction instrumentation).

Currently, Entest is focused on research and development in areas of COPD and Immuno-Therapeutic Cancer Vaccines. The Company sees applications for its patent pending technologies in both human and animal venues.

Immuno-therapeutic treatment of cancer - The patent pending Entest application involves perfecting the use of cell lines for sustained release of immunologically relevant cytokines for maximum anti-tumor immune responses in treating cancer. The treatment process itself will utilize an implantable encapsulation device as the vaccine delivery system and the initial focus will be treatment of cancer in canines. This canine cancer treatment may also provide clinical support for expansion into human cancer treatment.

Chronic Obstructive Pulmonary Disease -There is currently no cure for COPD and therapy is limited to management of the condition and its symptoms. Over the next 5 years, it is estimated that over $170 billion will be spent on treating COPD in the United States. Entest believes its COPD treatment, which utilizes patent pending adult stem cell therapy coupled with photoceutical device enhancement, has the potential to reverse COPD related lung damage as well as alleviate symptoms.

Entest BioMedical was founded for the purpose of providing excellence in biotechnology research (including adult stem cell regenerative treatment). Our objectives go beyond developing single products and procedures. Our mission is to discover and develop new procedures, treatments and medical devices that improve the quality of life. Our efforts revolve around a business focus of developing leading research and technology. Ongoing R&D is paramount to us in developing products and procedures with purpose, products and services that serve the present and help shape the future.

 

Management: 

David R. Koos, PhD, DBA - Chairman and CEO, Secretary, Acting CFO
Feng Lin, MD, PhD - Director of Research
Marilyn Panahi - Director of Quality Assurance



 

 

http://www.entb.net
 

 Recent News!

June 1, 2015

 http://www.marketwired.com/press-release/entest-biomedical-inc-discussions-acquire-nanotechnology-delivery-system-cancer-therapy-otc-pink-entb-2025182.htm

 

 

 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ENTB
Current Price
Volume:
Bid Ask Day's Range
Wiki
ENTB News: Quarterly Report (10-q) 01/14/2016 12:11:12 PM
ENTB News: Annual Report (10-k) 11/27/2015 08:16:43 AM
ENTB News: Current Report Filing (8-k) 10/02/2015 03:06:12 PM
PostSubject
#37701   Been gone.....is ENTB dead? cwbuff 02/12/16 01:26:12 PM
#37699   Any time, I am still learning about investing ctvette2003 01/14/16 02:58:43 PM
#37698   Thank you for that link ctvette. I didn't psk3091 01/14/16 02:51:43 PM
#37697   http://www.investopedia.com/terms/f/fiscalyearend.asp ctvette2003 01/14/16 02:45:09 PM
#37696   ctvette I realize that, but even fiscal would need psk3091 01/14/16 02:40:38 PM
#37695   Fiscal yr and not calendar yr. ctvette2003 01/14/16 02:15:17 PM
#37694   Since when does a Quarter end at the psk3091 01/14/16 01:43:34 PM
#37693   10q out. ronrooster 01/14/16 12:48:38 PM
#37692   I totally understand the cynicism and frustration with JokersWild12 01/08/16 10:32:07 AM
#37690   Emotions always have to be checked at the Brakeman 01/07/16 04:11:41 PM
#37689   Brakeman, with your Wharton School business degree, why Fitzgerald 01/07/16 03:13:45 PM
#37688   Thanks, but I will go with Dr. David sizzleweed 01/06/16 08:31:17 PM
#37687   Just using my Wharton school of business degree Brakeman 01/06/16 10:28:16 AM
#37686   Are you looking for pity? ENTB GM_FSJ 01/06/16 10:07:01 AM
#37685   When someone who talks up his business at Brakeman 01/06/16 09:11:05 AM
#37684   An oral for dogs, Palladia from Pfizer, has sizzleweed 01/05/16 04:24:34 PM
#37683   Interest in ENTB is increasing sharply. 2016 will sizzleweed 01/05/16 12:22:01 AM
#37682   2016, the stem cell awakens. Wait for blockbuster sizzleweed 01/03/16 05:17:28 PM
#37681   Happy New Year everyone! Rk3 01/01/16 01:41:41 AM
#37680   Bottom by AUTUMN. Yes indeed, 20 bucks traded sizzleweed 12/30/15 02:28:26 AM
#37679   ~ ENTB = .0064 -.0086 (-57.33%)LOD..so..farRr! :-( 1~Eye~Jack!! 12/29/15 12:52:50 PM
#37678   when is Koos going to do something about Crocs69 12/29/15 09:33:56 AM
#37677   The only approval this ATM has for investors Brakeman 12/27/15 10:13:15 AM
#37676   .40 to .50 was before the FDA APPROVAL sizzleweed 12/23/15 11:42:57 PM
#37675   Wow, who bought their wife 3 shares of sizzleweed 12/23/15 11:27:32 PM
#37674   the numbers on this board don't jive with jhenmal 12/23/15 07:00:36 PM
#37673   Koos and the Scientist Controlled 1.8 billion shares Brakeman 12/23/15 11:26:07 AM
#37672   LOL, I was musing about the dollar plus sizzleweed 12/22/15 10:20:19 PM
#37671   24 million shares out there? Anyone? Think of sizzleweed 12/22/15 09:25:29 PM
#37670   Directly it will have impact. With Koos and sizzleweed 12/22/15 09:16:55 PM
#37669   But no volume. Focus your attention on the cadillac107 12/22/15 09:12:13 PM
#37668   Huge spike! Someone bought shares for little Jedidiah's sizzleweed 12/22/15 09:06:44 PM
#37667   Yes I get all that, but thats is ctvette2003 12/22/15 12:41:09 PM
#37666   NR2F6 has its origin with Christine Ichim and JokersWild12 12/22/15 12:38:27 PM
#37665   Do you really think RGBP will have an ctvette2003 12/22/15 08:59:31 AM
#37664   Good to see the core group is still sizzleweed 12/21/15 02:39:54 PM
#37663   Can I join the "M2" club (Me Too!)? bucks2pennies 12/21/15 01:37:50 PM
#37662   Thanks Kbro13! What is your thought on the sizzleweed 12/19/15 07:09:41 PM
#37661   Still here with your Sizzle! Kbro13 12/19/15 11:51:23 AM
#37660   Sizzle,we have been here for a while and JokersWild12 12/19/15 10:53:37 AM
#37659   Thanks, Jokers wild 12! Certainly great DD. Having sizzleweed 12/18/15 09:32:31 PM
#37658   I guess everyone is bailing for RGB*. ENTB sizzleweed 12/18/15 02:33:51 PM
#37657   It does look like these entities are now JokersWild12 12/16/15 08:04:03 PM
#37656   http://www.prnewswire.com/news-releases/regen-biopharma-inc-receives-fda-clearan sizzleweed 12/15/15 02:03:43 PM
#37655   Surer hope it has an impact here too ctvette2003 12/15/15 08:10:18 AM
#37654   Oooooh yeh. This is the magic I prof81 12/15/15 07:57:18 AM
#37653   Nice pop today, something coming down the pipeline? 72chevnj 12/14/15 05:16:28 PM
#37652   Secret batch of stem cells being made. prof81 12/14/15 10:25:58 AM
#37651   Everyone is about to load up, everyone jeffshir 12/11/15 01:41:08 PM
#37650   So someone spent .132 + commissions? MMs suck ctvette2003 12/07/15 12:43:14 PM
PostSubject